JP2016510218A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510218A5 JP2016510218A5 JP2015557162A JP2015557162A JP2016510218A5 JP 2016510218 A5 JP2016510218 A5 JP 2016510218A5 JP 2015557162 A JP2015557162 A JP 2015557162A JP 2015557162 A JP2015557162 A JP 2015557162A JP 2016510218 A5 JP2016510218 A5 JP 2016510218A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecules
- time
- flight channels
- complements
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000039446 nucleic acids Human genes 0.000 claims description 134
- 108020004707 nucleic acids Proteins 0.000 claims description 134
- 150000007523 nucleic acids Chemical class 0.000 claims description 134
- 238000000034 method Methods 0.000 claims description 81
- 125000003729 nucleotide group Chemical group 0.000 claims description 47
- 239000002773 nucleotide Substances 0.000 claims description 40
- 239000000523 sample Substances 0.000 claims description 40
- 239000007787 solid Substances 0.000 claims description 36
- 102000004190 Enzymes Human genes 0.000 claims description 33
- 108090000790 Enzymes Proteins 0.000 claims description 33
- 230000000295 complement effect Effects 0.000 claims description 30
- 239000000758 substrate Substances 0.000 claims description 24
- 238000003776 cleavage reaction Methods 0.000 claims description 17
- 230000007017 scission Effects 0.000 claims description 17
- 238000012163 sequencing technique Methods 0.000 claims description 17
- 108091034117 Oligonucleotide Proteins 0.000 claims description 10
- 230000005684 electric field Effects 0.000 claims description 9
- 239000000178 monomer Substances 0.000 claims description 9
- 108060002716 Exonuclease Proteins 0.000 claims description 6
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 6
- 102000013165 exonuclease Human genes 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000002751 oligonucleotide probe Substances 0.000 claims description 6
- 239000013615 primer Substances 0.000 claims description 6
- 108010002700 Exoribonucleases Proteins 0.000 claims description 5
- 102000004678 Exoribonucleases Human genes 0.000 claims description 5
- 229920001222 biopolymer Polymers 0.000 claims description 5
- 239000003155 DNA primer Substances 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 229920001519 homopolymer Polymers 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002070 nanowire Substances 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 108020004635 Complementary DNA Proteins 0.000 claims description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 3
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims description 2
- 229910000510 noble metal Inorganic materials 0.000 claims description 2
- 108091006146 Channels Proteins 0.000 description 67
- 229940088598 enzyme Drugs 0.000 description 28
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 12
- 229920001184 polypeptide Polymers 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- 102000004196 processed proteins & peptides Human genes 0.000 description 11
- 102000007079 Peptide Fragments Human genes 0.000 description 9
- 108010033276 Peptide Fragments Proteins 0.000 description 9
- 102000053602 DNA Human genes 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- 229920002477 rna polymer Polymers 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000033616 DNA repair Effects 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- -1 apoptosis regulator Proteins 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 3
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 3
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 3
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 102000018120 Recombinases Human genes 0.000 description 3
- 108010091086 Recombinases Proteins 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000005945 translocation Effects 0.000 description 3
- 108700011259 MicroRNAs Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- 108091046869 Telomeric non-coding RNA Proteins 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 210000001808 exosome Anatomy 0.000 description 2
- 238000007672 fourth generation sequencing Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 108020004418 ribosomal RNA Proteins 0.000 description 2
- 239000004055 small Interfering RNA Substances 0.000 description 2
- 108010068698 spleen exonuclease Proteins 0.000 description 2
- 230000005641 tunneling Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 101000898643 Candida albicans Vacuolar aspartic protease Proteins 0.000 description 1
- 101000898783 Candida tropicalis Candidapepsin Proteins 0.000 description 1
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 101000898784 Cryphonectria parasitica Endothiapepsin Proteins 0.000 description 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 102100030011 Endoribonuclease Human genes 0.000 description 1
- 101710199605 Endoribonuclease Proteins 0.000 description 1
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 1
- 102100029075 Exonuclease 1 Human genes 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 102000003964 Histone deacetylase Human genes 0.000 description 1
- 108090000353 Histone deacetylase Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108090000543 Ligand-Gated Ion Channels Proteins 0.000 description 1
- 102000004086 Ligand-Gated Ion Channels Human genes 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 1
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 101000933133 Rhizopus niveus Rhizopuspepsin-1 Proteins 0.000 description 1
- 101000910082 Rhizopus niveus Rhizopuspepsin-2 Proteins 0.000 description 1
- 101000910079 Rhizopus niveus Rhizopuspepsin-3 Proteins 0.000 description 1
- 101000910086 Rhizopus niveus Rhizopuspepsin-4 Proteins 0.000 description 1
- 101000910088 Rhizopus niveus Rhizopuspepsin-5 Proteins 0.000 description 1
- 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 description 1
- 101710204410 Scaffold protein Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 101710113029 Serine/threonine-protein kinase Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 102000039471 Small Nuclear RNA Human genes 0.000 description 1
- 108020003224 Small Nucleolar RNA Proteins 0.000 description 1
- 102000042773 Small Nucleolar RNA Human genes 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 1
- 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 108010032819 exoribonuclease II Proteins 0.000 description 1
- 108010055863 gene b exonuclease Proteins 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000002090 nanochannel Substances 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 108091029842 small nuclear ribonucleic acid Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361762671P | 2013-02-08 | 2013-02-08 | |
| US61/762,671 | 2013-02-08 | ||
| PCT/US2014/015574 WO2014124365A2 (en) | 2013-02-08 | 2014-02-10 | Biomolecular processing platform and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510218A JP2016510218A (ja) | 2016-04-07 |
| JP2016510218A5 true JP2016510218A5 (enExample) | 2017-03-02 |
| JP6388605B2 JP6388605B2 (ja) | 2018-09-12 |
Family
ID=51300273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015557162A Active JP6388605B2 (ja) | 2013-02-08 | 2014-02-10 | 生体分子処理プラットフォーム及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9909173B2 (enExample) |
| EP (1) | EP2954103B1 (enExample) |
| JP (1) | JP6388605B2 (enExample) |
| CN (1) | CN105026002B (enExample) |
| AU (1) | AU2014214709B2 (enExample) |
| CA (1) | CA2896674C (enExample) |
| WO (1) | WO2014124365A2 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3024582A4 (en) * | 2013-07-22 | 2017-03-08 | President and Fellows of Harvard College | Microfluidic cartridge assembly |
| US10058895B2 (en) * | 2014-11-26 | 2018-08-28 | International Business Machines Corporation | Continuous flow, size-based separation of entities down to the nanometer scale using nanopillar arrays |
| DE102014226138A1 (de) | 2014-12-16 | 2016-06-16 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zum Herstellen einer Vorrichtung mit einer dreidimensionalen magnetischen Struktur |
| US20160187282A1 (en) * | 2014-12-26 | 2016-06-30 | Intel Corporation | Device for single molecule detection and fabrication methods thereof |
| US10393726B2 (en) | 2015-03-23 | 2019-08-27 | The University Of North Carolina At Chapel Hill | Universal molecular processor for precision medicine |
| US10829804B2 (en) | 2015-03-23 | 2020-11-10 | The University Of North Carolina At Chapel Hill | Method for identification and enumeration of nucleic acid sequences, expression, splice variant, translocation, copy, or DNA methylation changes using combined nuclease, ligase, polymerase, terminal transferase, and sequencing reactions |
| DE102015219023B3 (de) | 2015-10-01 | 2017-02-23 | Technische Universität München | Vorrichtung zum Analysieren von biologischen Substanzen in einer Testlösung, Herstellungsverfahren und Betriebsverfahren |
| CN105466896A (zh) * | 2015-11-23 | 2016-04-06 | 江南大学 | 核酸适配体功能化磁纳米颗粒分离富集-激光诱导荧光检测金黄色葡萄球菌 |
| CA3014773C (en) | 2016-03-07 | 2025-11-18 | Father Flanagan's Boys' Home Doing Business As Boys Town National Research Hospital | NON-INVASIVE MOLECULAR WITRS |
| CN105806897B (zh) * | 2016-03-21 | 2019-03-26 | 蔡俊豪 | 一种奶瓶消毒提醒装置及奶瓶消毒提醒方法 |
| DE102016215616B4 (de) | 2016-08-19 | 2020-02-20 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zum Herstellen einer magnetischen Struktur und Vorrichtung |
| DE102016215617A1 (de) | 2016-08-19 | 2018-02-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zum Herstellen eines Hohlraums mit poröser Struktur |
| US11565258B2 (en) * | 2016-10-03 | 2023-01-31 | Genvida Technology Company Limited | Method and apparatus for the analysis and identification of molecules |
| EP3559628B1 (en) * | 2016-12-22 | 2021-08-18 | Ventana Medical Systems, Inc. | System and method for sample processing |
| US20190064061A1 (en) * | 2017-08-26 | 2019-02-28 | Innovative Micro Technology | Gas sensor using vcsel |
| SG11202010093QA (en) * | 2018-05-07 | 2020-11-27 | Applied Materials Inc | Substrate deformation detection and correction |
| US11185861B2 (en) * | 2018-06-13 | 2021-11-30 | International Business Machines Corporation | Multistage deterministic lateral displacement device for particle separation |
| WO2020014708A1 (en) | 2018-07-13 | 2020-01-16 | University Of Kansas | Nanofluidic analytical devices and methods of using thereof |
| WO2020023417A1 (en) * | 2018-07-23 | 2020-01-30 | Enclear Therapies, Inc. | Methods of treating neurological disorders |
| CN113164557A (zh) | 2018-07-23 | 2021-07-23 | 因柯利尔疗法公司 | 治疗神经性病症的方法 |
| CN110794141B (zh) * | 2018-08-01 | 2021-05-18 | 清华大学 | 鉴定生物分子链中多对生物分子间相互作用调控因子的方法 |
| US10704094B1 (en) | 2018-11-14 | 2020-07-07 | Element Biosciences, Inc. | Multipart reagents having increased avidity for polymerase binding |
| US10876148B2 (en) | 2018-11-14 | 2020-12-29 | Element Biosciences, Inc. | De novo surface preparation and uses thereof |
| EP3917392B1 (en) * | 2019-01-28 | 2024-09-18 | Abbott Diabetes Care Inc. | Analyte sensors and sensing methods for detecting creatinine |
| EP3952947A4 (en) | 2019-04-11 | 2024-07-03 | Enclear Therapies, Inc. | METHODS FOR IMPROVING CSF AND DEVICES AND SYSTEMS THEREFOR |
| US11543429B2 (en) * | 2019-04-25 | 2023-01-03 | Morgan State University | Nanoscale scanning electrochemical microscopy electrode method |
| CN110097927B (zh) * | 2019-05-10 | 2022-09-02 | 青岛理工大学 | 基于分子动力学测试电场作用下离子扩散系数的方法 |
| EP3845667A1 (en) | 2019-12-30 | 2021-07-07 | Industrial Technology Research Institute | Method of amplifying and determining target nucleotide sequence |
| CN111521766B (zh) * | 2020-04-10 | 2022-02-15 | 浙江大学 | 人工合成的大环结构分子纳米孔结构及制备方法及应用 |
| AU2021355470A1 (en) | 2020-09-29 | 2023-06-01 | Enclear Therapies, Inc. | Subarachnoid fluid management method and system |
| CN112501267B (zh) * | 2020-11-17 | 2022-08-26 | 中国科学院北京基因组研究所(国家生物信息中心) | 一种rna外切酶-纳米孔复合体及其制备方法和应用 |
| JP2024510408A (ja) * | 2021-03-02 | 2024-03-07 | アイデックス ラボラトリーズ インコーポレイテッド | エポキシ系樹脂に付着した生化学プローブ |
| US11845079B2 (en) | 2021-12-08 | 2023-12-19 | International Business Machines Corporation | Integrated silicon platform for electronic biosensors |
| CN114415056B (zh) * | 2022-01-17 | 2025-07-04 | 四川轻化工大学 | 一种分布式电源孤岛故障的检测方法 |
| WO2025049705A1 (en) * | 2023-09-01 | 2025-03-06 | Han Cao | Devices and methods for preparing macromolecule spreads |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1047108B1 (en) | 1999-04-06 | 2006-03-08 | Micromass UK Limited | A method of determining peptide sequences by mass spectrometry |
| CA2303761C (en) | 1999-04-06 | 2005-12-20 | Micromass Limited | A method of determining peptide sequences by mass spectrometry |
| US8481268B2 (en) * | 1999-05-21 | 2013-07-09 | Illumina, Inc. | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
| US7358048B2 (en) * | 2004-02-10 | 2008-04-15 | Cornell Research Foundation, Inc. | Method for detection of promoter methylation status |
| US20070117104A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
| US7422866B2 (en) * | 2005-08-10 | 2008-09-09 | Agilent Technologies, Inc. | On-line enzymatic digestion in separation-detection methods |
| EP2014761B1 (en) * | 2007-06-22 | 2016-09-28 | Sony Deutschland GmbH | A device for processing an analyte and a method of processing and/or detecting an analyte using said device |
| EP2715777A4 (en) * | 2011-06-02 | 2015-03-04 | Wisconsin Alumni Res Found | MEMBRANE DETECTOR FOR AIR-TIME MASS SPECTROMETRY |
| US9670540B2 (en) * | 2011-07-21 | 2017-06-06 | Cornell University | Methods and devices for DNA sequencing and molecular diagnostics |
-
2014
- 2014-02-10 EP EP14749210.2A patent/EP2954103B1/en active Active
- 2014-02-10 WO PCT/US2014/015574 patent/WO2014124365A2/en not_active Ceased
- 2014-02-10 CA CA2896674A patent/CA2896674C/en active Active
- 2014-02-10 US US14/763,972 patent/US9909173B2/en active Active
- 2014-02-10 JP JP2015557162A patent/JP6388605B2/ja active Active
- 2014-02-10 AU AU2014214709A patent/AU2014214709B2/en active Active
- 2014-02-10 CN CN201480008025.4A patent/CN105026002B/zh active Active
-
2018
- 2018-02-19 US US15/898,943 patent/US10870881B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016510218A5 (enExample) | ||
| US20250019742A1 (en) | Concentrating a target molecule for sensing by a nanopore | |
| EP1157264B1 (en) | Biochemical purification devices with immobilized capture probes and their uses | |
| US9574228B2 (en) | Nanopore-facilitated single molecule detection of nucleic acids | |
| CN104254771B (zh) | 基于纳米孔的分子检测与测序 | |
| EP2814983B1 (en) | Methods for creating bilayers for use with nanopore sensors | |
| US11274341B2 (en) | Assay methods using DNA binding proteins | |
| EP3733874A1 (en) | Unidirectional sequencing using pandomers | |
| WO2017125565A1 (en) | Nanopore sequencing complexes | |
| JP2001519658A (ja) | 相互作用する分子の解離 | |
| US10294516B2 (en) | Enhanced probe binding | |
| CN105593409A (zh) | 传感器生长控制器 | |
| US20220064720A1 (en) | Isolation of target nucleic acids | |
| EP4026916B1 (en) | Nanopore/nanowell electrode enabled exonuclease sequencing | |
| EP3830572A1 (en) | Nanopore device and methods of detecting charged particles using same | |
| US20180148772A1 (en) | Method for Quantitatively Profiling Nucleic Acids | |
| US12179197B2 (en) | Microfluidic sequencing device for multiplying and separating molecular chains, and method for separating molecular chains obtained from an amplification reaction | |
| Xu | Biological Computing Operators: Enzymes and Biochemical Operations | |
| Ali et al. | Molecular Techniques Used to Identify the DNA Sequences |